OVERVIEW

[Diabetes Trends] Treating Diabetes Beyond A1C: Considerations for Cardiovascular Protection is organized by Horizon CME and will be held from Dec 20, 2018 - Dec 20, 2019.

Target Audience:
The target audience for this educational activity is primary care physicians (internal medicine, family practice MD/DOs), nurse practitioners (NPs), and physician assistants (PAs) who practice in a primary care setting. This Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Overview:
This webcast will review the safety and efficacy of recent trials for SGLT-2 inhibitors and GLP-1 RAs on cardiovascular outcomes in patients with diabetes. This activity will also explore the impact that diabetes agents with positive CV outcomes have on cardiometabolic markers and how CV outcomes data may impact management of patients with type 2 diabetes.

Learning Objectives:
• Review the safety and efficacy of recent trials for SGLT-2 inhibitors and GLP-1 RAs on cardiovascular outcomes in patients with diabetes
• Discuss the effects of diabetes agents with positive CV outcomes have on Cardiometabolic markers including lipids, blood pressure, weight, A1C, and hypoglycemia risk
• Assess the impact of CV outcomes data for the practical management of patients with type 2 diabetes